Meta-analysis of individual participant data: rationale, conduct, and reporting
暂无分享,去创建一个
[1] S. Haque. Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed. , 2011 .
[2] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[3] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[4] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[5] P. Vedsted,et al. [From science to practice]. , 2009, Ugeskrift for laeger.
[6] Anne Whitehead,et al. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials , 2009, Clinical trials.
[7] David J Spiegelhalter,et al. A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.
[8] Richard D Riley,et al. Meta‐analysis of diagnostic test studies using individual patient data and aggregate data , 2008, Statistics in medicine.
[9] Richard D Riley,et al. Meta‐analysis of continuous outcomes combining individual patient data and aggregate data , 2008, Statistics in medicine.
[10] Richard D Riley,et al. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. , 2007, Journal of clinical epidemiology.
[11] Mark R. Trusheim,et al. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.
[12] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[13] Ewout W Steyerberg,et al. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? , 2006, Annals of epidemiology.
[14] Keith R Abrams,et al. Meta‐analysis of heterogeneously reported trials assessing change from baseline , 2005, Statistics in medicine.
[15] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[16] Mark C Simmonds,et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.
[17] Paula R Williamson,et al. Investigating heterogeneity in an individual patient data meta‐analysis of time to event outcomes , 2005, Statistics in medicine.
[18] K. Gelmon,et al. The 2000 EBCTCG overview: a widening gap , 2005, The Lancet.
[19] François Gueyffier,et al. Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome , 2005, Hypertension.
[20] Simon G Thompson,et al. Can meta-analysis help target interventions at individuals most likely to benefit? , 2005, The Lancet.
[21] A. Grant,et al. Value of updating a systematic review in surgery using individual patient data , 2004, The British journal of surgery.
[22] Patrick Royston,et al. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer , 2004, Statistics in medicine.
[23] John P A Ioannidis,et al. Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.
[24] L. Stewart,et al. To IPD or not to IPD? , 2002, Evaluation & the health professions.
[25] Harold I Feldman,et al. Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.
[26] N. Brünner,et al. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. , 2002, Journal of the National Cancer Institute.
[27] P C Lambert,et al. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.
[28] D. Altman,et al. Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.
[29] A Whitehead,et al. Meta‐analysis of ordinal outcomes using individual patient data , 2001, Statistics in medicine.
[30] A Whitehead,et al. Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.
[31] D J Hutchon,et al. Publishing raw data and real time statistical analysis on e-journals , 2001, BMJ : British Medical Journal.
[32] H Goldstein,et al. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.
[33] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[34] T. Mathew,et al. On the Equivalence of Meta‐Analysis Using Literature and Using Individual Patient Data , 1999, Biometrics.
[35] I Olkin,et al. Comparison of meta-analysis versus analysis of variance of individual patient data. , 1998, Biometrics.
[36] George Davey Smith,et al. Meta-analysis: Beyond the grand mean? , 1997, BMJ.
[37] L. Stewart,et al. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.
[38] L F Burmeister,et al. A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. , 1995, JAMA.
[39] L. Stewart,et al. From science to practice. Meta-analyses using individual patient data are needed. , 1995 .
[40] M. Parmar,et al. Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.
[41] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.